Shares of Pandora were under pressure after rival Spotify announced will launch a competing web radio service .
And Arena Pharmaceuticals hit another 52-week high after investors felt confident that a decision on its potential blockbuster drug for obesity, Lorcaserin will not be delayed and could portend good news. According to StreetInsider.com, with or without a delay, most expect that the FDA will follow the advice of their panel and back Lorcaserin. No delay could mean a “first mover” advantage for the company.
Follow me on twitter @LoriSpechler and read more of my posts on http://marketinsider.cnbc.com
DisclaimerPage 2 of 2 | Prev Page